| Decades of experience, strong patient support, and more. |
View online |
|
|
|
|
| NovoSeven® RT is used to treat bleeding episodes in people with hemophilia A or B with inhibitors, congenital Factor VII deficiency, Glanzmann’s thrombasthenia with resistance to platelets, and acquired hemophilia. |
|
|
|
| Trusted for over 30 years |
| NovoSeven® RT was the first recombinant factor VIIa (rFVIIa) therapy approved for hemophilia A and B with inhibitors, and it’s the only rFVIIa treatment approved for all ages—children, adolescents, and adults. |
|
|
 |
| Bob, Chase and Sid live with hemophilia A with inhibitors. Miguel lives with hemophilia B with inhibitors. |
| Scroll to learn whether NovoSeven® RT is right for you. |
 |
|
| Selected Important Safety Information |
| What is the most important information I should know about NovoSeven® RT? |
| NovoSeven® RT may cause serious side effects, including: |
| |
• |
Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported |
|
| |
• |
Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function |
|
| |
• |
Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT |
|
| Please click here or scroll below for additional Important Safety Information. |
|
|
 |
| Important “factors” you should know about |
| NovoSeven® RT offers fast bleed control for even the most life-threatening bleedsa—it’s 90% effective in all severe bleeding episodes.b And, it has a proven safety profile for use before, during, and after surgery. |
|
|
aIn compassionate use situations including surgery, central nervous system hemorrhages, severe intra-abdominal bleeding, and other life-threatening bleeding episodes.
bFor hemophilia patients with inhibitors. Data shown from compassionate use program and 2 clinical studies. |
|
|
 |
Dosing designed
with you in mind |
| NovoSeven® RT is available in 4 vial sizes, more than any other rFVIIa therapy, so you might need fewer vials to infuse your dose. And, you can infuse quickly, in 2-5 minutes.c |
|
|
| cAdminister as a slow bolus injection over 2-5 minutes, depending on the dose administered. |
|
|
|
| Get support when you need it |
| We offer comprehensive, personalized support so you can focus on enjoying your life. With NovoCare®, you’ll receive: |
- One-on-one access to a NovoCare® Specialist
- Financial product assistance
- Educational resources
|
|
|
|
|
|
| What is NovoSeven® RT? |
| NovoSeven® RT (coagulation Factor VIIa, recombinant) is an injectable medicine used for: |
| |
• |
Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, and Glanzmann’s thrombasthenia with a decreased or absent response to platelet transfusions |
|
| |
• |
Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults with acquired hemophilia |
|
| Important Safety Information (cont’d) |
| |
• |
You should not use NovoSeven® RT if you have ever had allergic (hypersensitivity) reactions, including severe, whole body reactions (anaphylaxis) to NovoSeven® RT, any of its ingredients, or mice, hamsters, or cows. Signs of allergic reaction include shortness of breath, rash, itching (pruritus), redness of the skin (erythema), or fainting/dizziness |
|
| What should I tell my healthcare provider before using NovoSeven® RT? |
| |
• |
Tell your healthcare provider if you have any of the following, as these may increase your risk of blood clots: |
| |
|
| |
◦ |
congenital hemophilia and are also receiving treatment with aPCCs (activated prothrombin complex concentrates) |
| |
◦ |
are an older patient particularly with acquired hemophilia and receiving other agents to stop bleeding |
| |
◦ |
history of heart or blood vessel diseases |
|
| |
• |
Tell your healthcare provider and pharmacist about all the medicines you take, including all prescription and non-prescription medicines, such as over-the-counter medicines, supplements, or herbal remedies |
|
| What are the possible side effects of NovoSeven® RT? |
| |
• |
The most common and serious side effects are blood clots |
|
| |
• |
Tell your healthcare provider about any side effects that bother you or do not go away, and seek medical help right away if you have signs of a blood clot or allergic reaction |
|
| Please click here for Prescribing Information. |
| NovoSeven® RT is a prescription medication. |
| You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. |
|
|
| PLEASE DO NOT RESPOND TO THIS EMAIL. If you would like to contact us, please click here or call 1‑877‑744‑2579. |
| UNSUBSCRIBE NOTICE |
| If you no longer want to receive communications from Novo Nordisk, click here to unsubscribe. You also may call us at 1-877-744-2579 or send us a letter that includes your full contact information (e.g. name, email address, phone) to Novo Nordisk, 800 Scudders Mill Road, Plainsboro, New Jersey 08536. To better understand how Novo Nordisk values your privacy, see our Privacy Statement. |
|
NovoSeven® is a registered trademark of Novo Nordisk Health Care AG.
NovoCare® is a registered trademark of Novo Nordisk A/S.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
© 2020 Novo Nordisk All rights reserved. US20NSVN00137 November 2020 |
 |
|
|
|